Drug Profile
Thymotrinan
Alternative Names: RGH 0205; TP3Latest Information Update: 24 Oct 2021
Price :
$50
*
At a glance
- Originator Gedeon Richter
- Class Antirheumatics
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Autoimmune disorders; Cancer; HIV infections; Rheumatic disorders
Most Recent Events
- 08 Nov 2006 Discontinued - Phase-II for Cancer in Hungary (unspecified route)
- 08 Nov 2006 Discontinued - Phase-II for HIV infections treatment in United Kingdom (unspecified route)
- 08 Nov 2006 Discontinued for Autoimmune disorders (unspecified route)